Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 64 Records) |
| Query Trace: Disease and SCT[original query] |
|---|
| Triglyceride/HDL-cholesterol ratio and plasminogen activator inhibitor-1 independently predict high pulse pressure in sickle cell trait and disease. Archives of physiology and biochemistry 2018 8 126 (2): 166-171. Olabode Olatunde P, Akinlade Olawale M, Babatunde Abiola S, Abdulazeez Musbau I, Biliaminu Sikiru A, Oyabambi Adewumi O, Olatunji Victoria A, Soladoye Ayodele O, Olatunji Lawrence |
| Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis. BMC cancer 2018 Jul 18 (1): 755. Shen Zhenglei, Gu Xuezhong, Mao Wenwen, Yin Liefen, Yang Ling, Zhang Zhe, Liu Kunmei, Wang Lilan, Huang Yunch |
| A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms. Blood advances 2018 7 2 (14): 1719-1737. Martínez-Laperche Carolina, Buces Elena, Aguilera-Morillo M Carmen, Picornell Antoni, González-Rivera Milagros, Lillo Rosa, Santos Nazly, Martín-Antonio Beatriz, Guillem Vicent, Nieto José B, González Marcos, de la Cámara Rafael, Brunet Salut, Jiménez-Velasco Antonio, Espigado Ildefonso, Vallejo Carlos, Sampol Antonia, Bellón José María, Serrano David, Kwon Mi, Gayoso Jorge, Balsalobre Pascual, Urbano-Izpizua Álvaro, Solano Carlos, Gallardo David, Díez-Martín José Luis, Romo Juan, Buño Ismael, |
| Common ?-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease. PLoS genetics 2018 Mar 14 (3): e1007293. Raffield Laura M, Ulirsch Jacob C, Naik Rakhi P, Lessard Samuel, Handsaker Robert E, Jain Deepti, Kang Hyun M, Pankratz Nathan, Auer Paul L, Bao Erik L, Smith Joshua D, Lange Leslie A, Lange Ethan M, Li Yun, Thornton Timothy A, Young Bessie A, Abecasis Goncalo R, Laurie Cathy C, Nickerson Deborah A, McCarroll Steven A, Correa Adolfo, Wilson James G, , Lettre Guillaume, Sankaran Vijay G, Reiner Alex |
| Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thrombosis journal 2018 10 16 27. Noubiap Jean Jacques, Temgoua Mazou N, Tankeu Ronni, Tochie Joel Noutakdie, Wonkam Ambroise, Bigna Jean Jo |
| Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL. Bone marrow transplantation 2019 5 54 (11): 1847-1858. Babor Florian, Peters Christina, Manser Angela R, Glogova Evgenia, Sauer Martin, Pötschger Ulrike, Ahlmann Martina, Cario Gunnar, Feuchtinger Tobias, Gruhn Bernd, Güngör Tayfun, Horn Peter A, Kremens Bernhard, Lang Peter, Mezger Markus, Müller Ingo, Mytilineos Joannis, Oevermann Lena, Pichler Herbert, Scherenschlich Nadine, Schuster Friedhelm R, Siepermann Meinolf, Stachel Daniel, Strahm Brigitte, Wössmann Wilhelm, Escherich Gabriele, Zimmermann Martin, Schrappe Martin, Borkhardt Arndt, Eckert Cornelia, Bader Peter, Uhrberg Markus, Meisel Rola |
| Association of sickle cell trait with atrial fibrillation: The REGARDS cohort. Journal of electrocardiology 2019 4 55 1-5. Douce Daniel R, Soliman Elsayed Z, Naik Rakhi, Hyacinth Hyacinth I, Cushman Mary, Winkler Cheryl A, Howard George, Lange Ethan M, Lange Leslie A, Irvin Marguerite R, Zakai Neil |
| NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood advances 2019 3 3 (6): 922-933. Montalban-Bravo Guillermo, Kanagal-Shamanna Rashmi, Sasaki Koji, Patel Keyur, Ganan-Gomez Irene, Jabbour Elias, Kadia Tapan, Ravandi Farhad, DiNardo Courtney, Borthakur Gautham, Takahashi Koichi, Konopleva Marina, Komrokji Rami S, DeZern Amy, Kuzmanovic Teodora, Maciejewski Jaroslaw, Pierce Sherry, Colla Simona, Sekeres Mikkael A, Kantarjian Hagop, Bueso-Ramos Carlos, Garcia-Manero Guiller |
| Study of association between sickle cell trait and renal dysfunction among young adults in South-west Nigeria. Nigerian journal of clinical practice 2019 2 22 (2): 201-207. Akinbodewa A A, Ogunleye A, Adejumo O A, Daomi V O, Okunola O, Oluwafemi T T, Alli E O, Olalusi V O, Osho P O, Lamidi O A, Fadipe F, Falekulo O |
| Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia. Annals of hematology 2019 Feb . Gao Xiao-Ning, Lin Ji, Wang Li-Jun, Li Fei, Li Hong-Hua, Wang Shu-Hong, Huang Wen-Rong, Gao Chun-Ji, Yu Li, Liu Dai-Ho |
| WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
| Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study. Cancer science 2020 5 111 (7): 2472-2481. Kawashima Naomi, Ishikawa Yuichi, Atsuta Yoshiko, Sawa Masashi, Ozawa Yukiyasu, Hayashi Masaki, Kohno Akio, Tomita Akihiro, Maeda Tomoya, Sakaida Emiko, Usuki Kensuke, Hagihara Maki, Kanamori Heiwa, Matsuoka Hiroshi, Kobayashi Miki, Asou Norio, Ohtake Shigeki, Matsumura Itaru, Miyazaki Yasushi, Naoe Tomoki, Kiyoi Hitoshi, |
| Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation. Annals of hematology 2020 Apr . Helbig Grzegorz, Kocl?ga Anna, Wieczorkiewicz-Kabut Agata, Wo?niczka Krzysztof, Kopi?ska Anna, Boral Kinga, Grygoruk-Wi?niowska Iwona, Stachowicz Ma?gorzata, Karolczyk Agniesz |
| MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leukemia research 2020 1 89 106296. Seipel Katja, Messerli Christian, Wiedemann Gertrud, Bacher Ulrike, Pabst Thom |
| Analysis of clinical presentation, hematological factors, self-reported bed net usage, and malaria burden in sickle cell disease patients. EClinicalMedicine 2021 8 39 101045. Harp Keri Oxendine, Botchway Felix, Dei-Adomakoh Yvonne, Wilson Michael D, Mubasher Mohamed, Adjei Andrew A, Thompson Winston E, Stiles Jonathan K, Driss Ad |
| Prevalence of ?-S Globin Haplotypes in Jazan Region of Saudi Arabia. Clinical laboratory 2021 8 67 (8): . Akhter Mohammad S, Mobarki Abdullah A, Hamali Hassan A, Saboor Muhammad, Madkhali Aymen M, Dobie Gasim, Hobani Yahya H, Eisa Zaki |
| Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 2021 6 36 (1): 257-262. Oran Betül, Champlin Richard E, Wang Feng, Tanaka Tomoyuki, Saliba Rima M, Al-Atrash Gheath, Garcia-Manero Guillermo, Kantarjian Hagop, Cao Kai, Shpall Elizabeth J, Alousi Amin M, Mehta Rohtesh S, Popat Uday, Futreal Andy, Takahashi Koic |
| Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank. The American journal of tropical medicine and hygiene 2021 Jun . Resurreccion W Kyle, Hulsizer Joseph, Shi Zhuqing, Wei Jun, Wang Chi-Hsiung, Na Rong, Zheng S Lilly, Struve Clay, Helfand Brian T, Khandekar Janardan, Billings Liana K, Caplan Michael S, Xu Jianfe |
| Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study. Clinical hematology international 2021 10 1 (1): 58-74. Bazarbachi Ali, Labopin Myriam, Battipaglia Giorgia, Djabali Azedine, Forcade Edouard, Arcese William, Socié Gerard, Blaise Didier, Halter Joerg, Gerull Sabine, Cornelissen Jan J, Chevallier Patrice, Maertens Johan, Schaap Nicolaas, El-Cheikh Jean, Esteve Jordi, Nagler Arnon, Mohty Moham |
| Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. JAMA network open 2021 1 4 (1): e2030435. Hyacinth Hyacinth I, Franceschini Nora, Seals Samantha R, Irvin Marguerite R, Chaudhary Ninad, Naik Rakhi P, Alonso Alvaro, Carty Cara L, Burke Gregory L, Zakai Neil A, Winkler Cheryl A, David Victor A, Kopp Jeffrey B, Judd Suzanne E, Adams Robert J, Gee Beatrice E, Longstreth W T, Egede Leonard, Lackland Daniel T, Greenberg Charles S, Taylor Herman, Manson JoAnn E, Key Nigel S, Derebail Vimal K, Kshirsagar Abhijit V, Folsom Aaron R, Konety Suma H, Howard Virginia, Allison Matthew, Wilson James G, Correa Adolfo, Zhi Degui, Arnett Donna K, Howard George, Reiner Alexander P, Cushman Mary, Safford Monika |
| The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation. Hematological oncology 2022 4 40 (3): 442-456. Shimazu Yutaka, Murata Makoto, Kondo Takeshi, Minami Yosuke, Tachibana Takayoshi, Doki Noriko, Uchida Naoyuki, Ozawa Yukiyasu, Yano Shingo, Fukuda Takahiro, Kato Jun, Ara Takahide, Eto Testuya, Ishikawa Jun, Nakamae Hirohisa, Tanaka Junji, Ichinohe Tatsuo, Atsuta Yoshiko, Nagamura-Inoue Tokiko, |
| Proliferative Retinopathy Associated with Repeated High-Altitude Exposure in a Patient with Sickle Cell Trait. High altitude medicine & biology 2022 12 23 (4): 369-371. Broadhead Geoffrey K, Wiley Henry E, Peprah David, Olumba Kenneth, Thavikulwat Alisa |
| Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 2022 1 97 (3): 329-337. Reville Patrick K, Sasaki Koji, Kantarjian Hagop M, Daver Naval G, Yilmaz Musa, Dinardo Courtney D, Short Nicholas J, Borthakur Gautam, Pemmaraju Naveen, Mehta Rohtesh S, Pierce Sherry, Konoplev Sergej N, Khoury Joseph D, Garcia-Manero Guillermo, Konopleva Marina Y, Jabbour Elias, Ravandi Farhad, Kadia Tapan |
| Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation. American journal of hematology 2022 1 97 (3): 274-282. Nagler Arnon, Labopin Myriam, Craddock Charles, Socié Gerard, Yakoub-Agha Ibrahim, Gedde-Dahl Tobias, Niittyvuopio Riitta, Byrne Jennifer Louise, Cornelissen Jan J, Labussière-Wallet Hélène, Arcese William, Milpied Noel, Esteve Jordi, Canaani Jonathan, Mohty Moham |
| PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia. Aging 2023 7 15 . Ling Wang, Chuang Jiang, Dandan |
| Hemoglobinopathies, merozoite surface protein-2 gene polymorphisms, and acquisition of Epstein Barr virus among infants in Western Kenya. BMC cancer 2023 6 23 (1): 566. Perez K Olewe, Shehu Shagari Awandu, Elly O Munde, Samuel B Anyona, Evans Raballah, Asito S Amolo, Sidney Ogola, Erick Ndenga, Clinton O Onyango, Rosemary Rochford, Douglas J Perkins, Collins Ou |
| Sickle Cell Hemoglobin Genotypes Affect Malaria Parasite Growth and Correlate with Exosomal miR-451a and let-7i-5p Levels. International journal of molecular sciences 2023 4 24 (8): . Keri Oxendine Harp, Alaijah Bashi, Felix Botchway, Daniel Addo-Gyan, Mark Tetteh-Tsifoanya, Amanda Lamptey, Georgina Djameh, Shareen A Iqbal, Cecilia Lekpor, Saswati Banerjee, Michael D Wilson, Yvonne Dei-Adomakoh, Andrew A Adjei, Jonathan K Stiles, Adel Dri |
| Sickle cell trait, APOL1 risk allele status and chronic kidney disease among ART-experienced adults living with HIV in northern Nigeria. International journal of STD & AIDS 2024 6 9564624241262397. Abdurrahman Abdulhamid, Bryan E Shepherd, Usman J Wudil, Chelsea Van Wyk, Faisal S Dankishiya, Nafiu Hussaini, C William Wester, Muktar H Ali |
| TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation. Cancer science 2024 12 . Teppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune, Gentaro Kawano, Takuya Harada, Yuichiro Semba, Masayasu Hayashi, Takahiro Shima, Yasuo Mori, Tetsuya Eto, Tomohiko Kamimura, Hiromi Iwasaki, Ryosuke Ogawa, Goichi Yoshimoto, Koji Kato, Takahiro Maeda, Toshihiro Miyamoto, Koichi Akas |
| Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia-related mutations in first remission. British journal of haematology 2024 11 . Ling Jiang, Jiaying Cheng, Junya Sun, Yujiao Zhang, Quan Wu, Yun Huang, Zhiquan Long, Ping Yan, Xuejie Jia |
- Page last reviewed:Feb 1, 2024
- Content source: